Psychology Today

Childhood-Onset Fluency Disorder

Childhood-onset fluency disorder is a communication disorder characterized by a disturbance in the flow and timing of speech that is inappropriate for an individual’s age. Also referred to as ...
Yahoo Finance

Noema Pharma Announces Recruitment of First Patient in Orpheus Phase 2b Study of PDE10A Inhibitor gemlapodect in Adults with Childhood Onset Fluency Disorder

Study evaluating the safety and efficacy of gemlapodect (NOE-105) in adults with Childhood Onset Fluency Disorder (also known as stuttering) Top-line data expected in Q4 2023 BASEL, Switzerland and ...
Yahoo Finance

Noema Pharma Announces FDA Investigational New Drug (IND) Authorization for Orpheus Phase 2b Study of PDE10A Inhibitor Gemlapodect (NOE-105) in Childhood Onset Fluency Disorder

BASEL, Switzerland and BOSTON, June 27, 2022 (GLOBE NEWSWIRE) -- Noema Pharma, a clinical-stage biotech company targeting debilitating central nervous system (CNS) indications, today announces the US ...
HealthTech

Paragon Biosciences' CEO Jeff Aronin Announces $35 Million Series C Preferred Stock Raise for Emalex Biosciences

Despite there being a significant need, the development of drugs specifically to aid conditions like Tourette syndrome and child-onset fluency disorder (stuttering) has been slow. Recently, those ...